Business

July 30, 2014

Cempra Q2 loss quadruples as R&D costs rise

Cempra's net loss quadrupled in the second quarter as the Chapel Hill pharmaceutical company ramped up spending on clinical trials for the antibiotic products it is developing.

Related content

Comments

Videos

Editor's Choice Videos